Aspira Pathlab & Diagnostics Limited (BOM:540788)

BOM:540788 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	16.8	17.52	8.04	5.67	13.54
Short-Term Investments	-	3.92	5.81	17.83	2.89
Cash & Short-Term Investments	16.8	21.44	13.84	23.49	16.44
Cash Growth	-21.64%	54.87%	-41.07%	42.93%	38.39%
Accounts Receivable	17.34	23.52	22.42	23.39	44.91
Other Receivables	0.25	0.12	0.09	0.23	0.21
Receivables	17.59	23.63	22.52	23.61	45.13
Inventory	6.97	5.11	4.47	3.99	4.05
Prepaid Expenses	-	0.71	0.5	1.01	0.38
Other Current Assets	4.49	2.75	2.22	6.46	5.46
Total Current Assets	45.85	53.65	43.55	58.56	71.44
Property, Plant & Equipment	38.82	38.61	41.17	53.13	68.24
Long-Term Investments	-	18.59	-	-	-
Goodwill	33.06	26.52	26.52	26.52	26.52
Other Intangible Assets	0.15	0.14	0.18	0.44	0.97
Other Long-Term Assets	31.33	3.65	3.47	3.51	3.36
Total Assets	185.06	174.62	147.1	173.42	181.35

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	11.4	7.38	7.27	3.45	6.1
Accrued Expenses	1.15	7.03	5.77	5.01	4.69
Current Portion of Leases	8.78	8.27	6.98	6.75	6.47
Current Unearned Revenue	-	0.25	0.04	0.03	0.08
Other Current Liabilities	10.63	0.8	0.66	0.61	0.55
Total Current Liabilities	31.96	23.72	20.71	15.85	17.89
Long-Term Debt	13.51	12.06	10.77	9.62	8.59
Long-Term Leases	10.94	11.63	10.07	16.77	24.16
Pension & Post-Retirement Benefits	6.34	5.54	4.11	3.68	2.83
Other Long-Term Liabilities	-0	-0	-	-0	-
Total Liabilities	62.75	52.95	45.66	45.91	53.46

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	102.93	102.93	102.93	102.93	102.93
Additional Paid-In Capital	-	90.3	90.3	90.3	90.3
Retained Earnings	-	-120.87	-141.1	-115.03	-114.63
Comprehensive Income & Other	19.38	-	-	-	-
Total Common Equity	122.31	72.37	52.14	78.21	78.6
Shareholders' Equity	122.31	121.66	101.43	127.5	127.9
Total Liabilities & Equity	185.06	174.62	147.1	173.42	181.35

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	33.22	31.96	27.82	33.14	39.22
Net Cash (Debt)	-16.42	-10.52	-13.98	-9.64	-22.78
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-1.60	-1.02	-1.36	-0.94	-2.21
Filing Date Shares Outstanding	10.29	10.29	10.29	10.29	10.29
Total Common Shares Outstanding	10.29	10.29	10.29	10.29	10.29
Working Capital	13.89	29.92	22.84	42.72	53.56
Book Value Per Share	11.89	7.03	5.07	7.60	7.64
Tangible Book Value	89.1	45.71	25.44	51.25	51.11
Tangible Book Value Per Share	8.66	4.44	2.47	4.98	4.97
Machinery	-	77.71	77.67	75.07	73.85
Leasehold Improvements	-	20.46	20.05	20.05	20.05

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error